MarkBertramSostekMDAGAF, FACG

PubMed

• 76 citations
  Treatment of patients with persistent heartburn symptoms: a double-blind, randomized trial.
  Ronnie Fass, Stephen J. Sontag, Barry Traxler, Mark Sostek
  Clinical Gastroenterology and Hepatology. 2006-01-01
• 315 citations
  Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study
  Philip B. Miner, Philip O. Katz, Yusong Chen, Mark Sostek
  The American Journal of Gastroenterology. 2003-12-01
• 231 citations
  Treatment of chronic posterior laryngitis with esomeprazole.
  Michael F. Vaezi, Joel E. Richter, C Richard Stasney, Joseph R. Spiegel, Ralph A. Iannuzzi
  The Laryngoscope. 2006-02-01

Books/Book Chapters

•  
  Chapter: Chapter 63 
  Sostek MB and Becker JM.WB Saunders Co. Philadelphia
•  
  Sostek MBIn The Endocrinologist.. Vol. 3. No. 6, New YorkEdition 2,
•  
  Chapter: In Hepatology. Vol. 21. No. 2 
  Sostek MBElsevier Science., Amsterdam

Abstracts/Posters

• Is the Prevalence of Moderate to Severe Erosive Oesophagitis (EE) More Common than we think? A Demographic Characterisation of Patients with Los Angeles Grade C...
  Fennerty MB, Johanson J, Hwang C, Hoyle P and Sostek M, United European Gastroenterology Week
• Esomeprazole provides highly effective acid control that is equally wll maintained during sleep and active periods.
  Katz PO, Castell DO, Chen Y and Sostek MB, Am J Gastro
• Integrated Gastric Acidity to Evaluate Acid Suppression with PPI therapy: a five way crossover comparison.
  Miner PB, Chen Y and Sostek MB, Gastroenterology
• Esomeprazole 40 mg provides more effective intragastric acid suppression at steady state than standard doses of other proton pump inhibitors.
  Miner PB, Katz PO, Chen Y and Sostek MB, Gastroenterology
• Rationale for switching proton pump inhibitor (PPI) therapy: an intraindividual analysis of gastric acid suppression following treatment with different PPIs.
  Katz PO, Miner PB, Wilder-Smith CH, Chen Y and Sostek MB, Gastroenterology
• The impact of age on the severity of erosive esophagitis in patients with gastroesophageal reflux disease.
  Johnson DA, Roach A and Sostek M, Johnson DA, Roach A and Sostek M
• Esomeprazole capsule contents suspended in water can be efficiently delivered through nasogastric and gastrostomy tubes.
  White CM, Kalus J, Quercia R, Fortier C, Piotrowski A, Roach A and Sostek MB, Am J of Gastroenterol
• Safety and Tolerability of Double Dose Esomeprazole (40 mg twice daily).
  Richter J, Vaezzi M, Stasney RC, Shaker R, Ianuzzi R, Hwang C, Leathers T and Sostek MB, United European Gastroenterology Week
• Esomeprazole 40 mg vs lansoprazole 30 mg in healing and symptom relief in patients with moderate to severe erosive oesophagitis (Los Angeles Grade C & D).
  Fennerty MB, Johanson J, Hwang C, Hoyle P and Sostek M, United European Gastroenterology Week
• Esomeprazole 40 mg once daily and lansoprazole 30 mg twice daily for heartburn symptoms in patients with resistant GERD.
  Fass R, Traxler BM, Thomas S and Sostek MB, Am J Gastro
• Nasogastric (NG) Tube administration of the contents of an opened capsule suspended in water compared with oral administration in Healthy volunteers.
  Sostek MB, Chen Y and Skammer W. Esomeprazole, Society of Gastrointestinal Nurses and Associates Annual Meeting., Dallas, Texas
• Delivery of esomeprazole via a range of alternative routes.
  Herrera P and Sostek MB, Society of Gastrointestinal Nurses and Associates Annual Meeting, Dallas, Texas
• Safety and Tolerability of Double-Dose Esomeprazole (40mg Twice Daily).
  Vaezzi M, Richter J, Stasney RC, Hwang C, Leathers T and Sostek M, Society of Gastrointestinal Nurses and Associates Annual Meeting, Dallas, Texas
• An In Vitro Study of the administration of esomeprazole enteric-coated pellets through naso-gastric and gastrostomy tubes.
  Sostek MB, Blychert E, Karlsson A, and Hulthe A, Am J of Gastroenterol
• Follow up of low - grade dysplasia in Barrett’s esophagus.
  Pedrosa MC, Klein MA, Sostek MB, Clark KM and Schimmel EM, Gastroenterology
• Chronic gastrointestinal illness in Persian Gulf Veterans.
  Sostek MB, Jackson S, Linevsky JK, Schimmel E and Fincke G, American Gastroenterology Association
• Esophagoaortic fistula from adenocarcinoma: A rare cause of massive upper gastrointestinal bleeding.
  Sostek MB and Choi PM, American College of Gastroenterology
• Esomeprazole 40 mg twice daily maintains intragastric pH for more than 80% of a 24 hour time period.
  Katz PO, Castell DO, Chen Y and Sostek MB, Am J of Gastroenterol
• Positive Association Between Intragastric and Intraesophageal Acid Control and Healing of Los Angeles Grade C and D Erosive Esophagitis: Reslts of a Prospective Contro...
  Katz PO, Ginsberg GG, Hoyle P, Sostek MB, Monyak J and Silberg DG, Gastroenterology
• Relationship between Intragastric Acid Control and Healing Status in the Treatment of Moderate to Severe Erosive Esophagitis.
  Katz PO, Ginsberg GG, Hoyle PE, Sostek MB, Monyak JT and Silberg DG, Aliment Pharmacol Therapeutics
• Efficacy of esomeprazole 40 mg versus lansoprazole 30 mg for healing moderate to severe erosive esophagitis.
  Fennerty MB, Johanson JF, Hwang C, Sostek M, Aliment Pharmacol Ther
• Zollinger Ellison Syndrome Succesfully Treated with Esomeprazole.
  Sostek MB and Troiano FP, Practical Gastroenterology
• High prevalence of chronic gastrointestinal symptoms in a National Guard Unit of Persian Gulf Veterans.
  Sostek MB, Jackson S, Linevsky JK, Schimmel EM and Fincke BG, Am. J. Gastro
• Multipolar electrocoagulation and injection therapy in the treatment of acute lower gastrointestinal hemorrhage from a rectal ulcer.
  Sostek MB and Fine S, American Journal of Gastroenterology
• PN400 Significantly Reduces the Incidence of Gastric Ulcers Compared with Enteric Coated Naproxen In Patients Requiring Chronic NSAID Therapy Regardless of Low Dose As...
  Goldstein JL, Hochberg MC, Fort JG, Zhang Y and Sostek MB, Arthritis and Rheumatism, e.g. Doximity University
• Join now to see all